DOC

Value Q4, 24Q1, 25Q2, 25Q3, 25Q4, 25 TTM Total revenue 697.99 M702.89 M694.35 M705.87 M719.4 M 2.82 B Gross profit 420.96 M429.75 M418.17 M413.95 M719.4 M 1.98 B Operating expenses 320.6 M299.64 M298.39 M283.79 M292.09 M 1.17 B Selling/general/admin expenses 23.93 M26.12 M20.76 M19.91 M23.63 M 90.42 M Research & development ————— — Operating income 100.36 M130.11 M119.77 M130.16 M427.31 M 807.36 M Non-Operating Income, Total -33.09 M-6.13 M-3.06 M12.66 M66.49 M 69.97 M Interest expense, net of interest capitalized 70.51 M72.69 M75.06 M76.78 M80.64 M 305.18 M Non-Operating Income, excl. Interest Expenses -79.44 M-72.69 M-73.43 M-65.28 M-24.29 M -235.69 M Unusual income/expense -24.16 M-6.13 M-4.69 M1.16 M10.14 M 479 K Pretax income -3.34 M52.14 M41.4 M-111.05 M127.82 M 110.31 M Equity in earnings -108 K-2.15 M1.75 M-176.29 M2.71 M -173.98 M Taxes -14.01 M2.08 M2.38 M-1.21 M6.03 M 9.28 M Non-controlling/minority interest -7 M-7.2 M-7.22 M-6.57 M-6.87 M -27.85 M After tax other income/expense 4.48 M2.66 M2.56 M2.61 M2.51 M 10.33 M Net income before discontinued operations 4.55 M42.83 M31.67 M-117.12 M113.97 M 71.35 M Discontinued operations 0———— — Net income 4.55 M42.83 M31.67 M-117.12 M113.97 M 71.35 M Dilution adjustment ————— — Preferred dividends ————— — Diluted net income available to common stockholders 4.42 M42.36 M31.56 M-117.26 M113.85 M 70.51 M Basic earnings per share (Basic EPS) 0.020.060.05-0.170.16 0.1 Diluted earnings per share (Diluted EPS) 0.020.060.05-0.170.16 0.1 Average basic shares outstanding 675.68 M699.07 M695.19 M694.93 M696.03 M 2.79 B Diluted shares outstanding 676.23 M699.12 M695.19 M694.93 M696.04 M 2.79 B EBITDA 326.05 M347.81 M329.5 M335.88 M339.91 M 1.35 B EBIT 29.85 M60.42 M42.71 M52.58 M58.62 M 214.33 M Cost of revenue 277.03 M273.14 M276.18 M291.92 M— — Other cost of goods sold ————— — Depreciation & amortization (cash flow) 296.2 M287.4 M286.79 M283.3 M281.29 M 1.14 B